BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 48 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $5,683,000 | +68.7% | 5,508,000 | +74.2% | 0.00% | 0.0% |
| Q2 2018 | $3,369,000 | +188.7% | 3,162,000 | +177.9% | 0.00% | – |
| Q1 2018 | $1,167,000 | -56.0% | 1,138,000 | -54.0% | 0.00% | -100.0% |
| Q4 2017 | $2,651,000 | +52920.0% | 2,472,000 | +49340.0% | 0.00% | – |
| Q3 2017 | $5,000 | +150.0% | 5,000 | +150.0% | 0.00% | – |
| Q2 2017 | $2,000 | -88.9% | 2,000 | -87.5% | 0.00% | – |
| Q4 2016 | $18,000 | -84.1% | 16,000 | -83.0% | 0.00% | – |
| Q3 2016 | $113,000 | +276.7% | 94,000 | +248.1% | 0.00% | – |
| Q2 2016 | $30,000 | -85.7% | 27,000 | -85.2% | 0.00% | – |
| Q1 2016 | $210,000 | +54.4% | 182,000 | +73.3% | 0.00% | – |
| Q3 2015 | $136,000 | -92.1% | 105,000 | -90.5% | 0.00% | -100.0% |
| Q2 2015 | $1,718,000 | +57166.7% | 1,104,000 | +55100.0% | 0.00% | – |
| Q1 2015 | $3,000 | -96.1% | 2,000 | -97.3% | 0.00% | – |
| Q3 2014 | $77,000 | +20.3% | 73,000 | +17.7% | 0.00% | – |
| Q2 2014 | $64,000 | +60.0% | 62,000 | +67.6% | 0.00% | – |
| Q1 2014 | $40,000 | +100.0% | 37,000 | +94.7% | 0.00% | – |
| Q4 2013 | $20,000 | – | 19,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|